Table 1 Patient characteristics
No. of patients | % | Mean age at baseline (years) | s.d. | Median daily dosage (mg) | IQR b of daily dosage (mg) | Mean age at event | s.d. | Median length of prescription (days) | Exposed period | Unexposed period | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of events | Total follow-up time (patient-years) | No. of events | Total follow-up time (patient-years) | ||||||||||
All | 103 | 100 | 6.95 | 1.78 | 20 | 20 | 13.5 | 3.6 | 70 | 25 | 223.0 | 78 | 823.6 |
Male | 72 | 69.9 | 6.97 | 1.78 | 20 | 20 | 13.7 | 3.7 | 70 | 15 | 162.7 | 57 | 582.3 |
Female | 31 | 30.1 | 6.90 | 1.81 | 20 | 15 | 13.1 | 3.4 | 70 | 10 | 60.3 | 21 | 241.3 |
